Pharmacometabolomic Approach to Predict QT Prolongation in Guinea Pigs
Open Access
- 4 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e60556
Abstract
Drug-induced torsades de pointes (TdP), a life-threatening arrhythmia associated with prolongation of the QT interval, has been a significant reason for withdrawal of several medicines from the market. Prolongation of the QT interval is considered as the best biomarker for predicting the torsadogenic risk of a new chemical entity. Because of the difficulty assessing the risk for TdP during drug development, we evaluated the metabolic phenotype for predicting QT prolongation induced by sparfloxacin, and elucidated the metabolic pathway related to the QT prolongation. We performed electrocardiography analysis and liquid chromatography–mass spectroscopy-based metabolic profiling of plasma samples obtained from 15 guinea pigs after administration of sparfloxacin at doses of 33.3, 100, and 300 mg/kg. Principal component analysis and partial least squares modelling were conducted to select the metabolites that substantially contributed to the prediction of QT prolongation. QTc increased significantly with increasing dose (r = 0.93). From the PLS analysis, the key metabolites that showed the highest variable importance in the projection values (>1.5) were selected, identified, and used to determine the metabolic network. In particular, cytidine-5′-diphosphate (CDP), deoxycorticosterone, L-aspartic acid and stearic acid were found to be final metabolomic phenotypes for the prediction of QT prolongation. Metabolomic phenotypes for predicting drug-induced QT prolongation of sparfloxacin were developed and can be applied to cardiac toxicity screening of other drugs. In addition, this integrative pharmacometabolomic approach would serve as a good tool for predicting pharmacodynamic or toxicological effects caused by changes in dose.Keywords
This publication has 94 references indexed in Scilit:
- KEGG for integration and interpretation of large-scale molecular data setsNucleic Acids Research, 2011
- Mass spectrometric analysis of long‐chain lipidsMass Spectrometry Reviews, 2010
- Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolismProceedings of the National Academy of Sciences, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- Cellular basis of drug‐induced torsades de pointesBritish Journal of Pharmacology, 2008
- The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome DatabasesNucleic Acids Research, 2007
- Network‐based classification of breast cancer metastasisMolecular Systems Biology, 2007
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Comparative Tolerability of the Newer Fluoroquinolone AntibacterialsDrug Safety, 1999